Independent Case Study For Soligenix”s CTCL Drug, SGX301, Drives Bullish Sentiment Topline FLASH Trial Data Expected Q1 2020 – MENAFN.COM / Cdn Warrant News, Common Stock Warrants / By https://commonstockwarrants.com Independent Case Study For Soligenix”s CTCL Drug, SGX301, Drives Bullish Sentiment Topline FLASH Trial Data Expected Q1 2020 MENAFN.COM